These CD8 (+) T cells are characterized by the expression of activation and exhaustion markers and the immune checkpoint molecule programmed cell death protein 1 (PD-1), indicating their potential to promote liver injury during NASH (37, 44). The gene discussed is CD8A; the disease is metabolic dysfunction-associated steatohepatitis.